BIOTON S.A. (WSE: BIO)
Poland
· Delayed Price · Currency is PLN
3.180
0.00 (0.00%)
Dec 2, 2024, 10:47 AM CET
BIOTON Revenue
BIOTON had revenue of 41.98M PLN in the quarter ending September 30, 2024, a decrease of -17.20%. This brings the company's revenue in the last twelve months to 177.60M, down -16.10% year-over-year. In the year 2023, BIOTON had annual revenue of 181.64M, down -22.10%.
Revenue (ttm)
177.60M
Revenue Growth
-16.10%
P/S Ratio
1.52
Revenue / Employee
497.47K
Employees
359
Market Cap
270.04M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 181.64M | -51.52M | -22.10% |
Dec 31, 2022 | 233.16M | 70.13M | 43.01% |
Dec 31, 2021 | 163.03M | -58.75M | -26.49% |
Dec 31, 2020 | 221.79M | 19.76M | 9.78% |
Dec 31, 2019 | 202.03M | -39.13M | -16.23% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Krka, d. d. | 8.14B |
NEUCA S.A. | 12.34B |
Sopharma AD | 4.49B |
Synektik Spólka Akcyjna | 624.80M |
Celon Pharma S.A. | 209.54M |
Voxel S.A. | 492.41M |
Ryvu Therapeutics S.A. | 91.18M |
Selvita S.A. | 334.42M |